SERPINA4 and type 2 diabetes mellitus: Our results also confirmed that kallistatin expression can be induced by glucotoxicity and increased oxidative stress, which is associated with persistent hyperglycemia in T2DM, while its production in non-diabetic patients is primarily related to systemic inflammation.